Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
We are offering 2,000,000 American Depositary Shares, or ADSs, at the public offering price of $6.00 per ADS. Each ADS offered represents 40 of our ordinary shares, NIS 0.1 par value, or Ordinary Shares. This is our initial public offering in the United States.
__________________________________
Ordinary Shares currently outstanding 46,355,614 Ordinary Shares.
ADSs offered by us
2,000,000 ADSs representing 80,000,000 Ordinary Shares.
Ordinary Shares to be outstanding after this offering 127,885,524 Ordinary Shares.
https://www.sec.gov/Archives/edgar/data/1611746/000121390017002699/f424b4032217_therapixbio.htm
Tel-Aviv THERAPIX BIO
http://www.tase.co.il/Eng/General/Company/Pages/companyMainData.aspx?subDataType=0&companyID=001292&shareID=01095140
127,8/40 x $10,15 = 32M Mkt cap
$TRPX - $9.35 share = 29M Mkt cap
Similar companies:
$GWPH 2.76B Mkt cap (95 X)
$ZYNE - 246M Mkt cap (8 X)
$OWCP 188M Mkt cap (6 X)
$TRPX - $9.35 share = 29M Mkt cap
Similar companies:
$GWPH 2.76B Mkt cap (95 X)
$ZYNE - 246M Mkt cap (8 X)
$OWCP 188M Mkt cap (6 X)
Is $TRPX the next $ZYNE? Low float runner from $8 to $20+
Is $TRPX the next $ZYNE? Low float runner from $8 to $20+ https://t.co/ft4MfX3S3n $GWPH $CARA $INSY
— Lou Basenese (@LouBasenese) March 23, 2017
NASDAQ: TRPX cannabinoid-based drugs IPO
TEL AVIV, Israel, March 22, 2017 /PRNewswire/ --
Therapix Biosciences Ltd. (NASDAQ: TRPX) (TASE: THXBY), a specialty clinical-stage pharmaceutical company specializing in the development of cannabinoid-based drugs, today announced the pricing of its initial public offering in the United States of 2,000,000 American Depository Shares ("ADSs"). Each ADS, representing 40 ordinary shares of the Company, is offered at a price to the public of $6.00.
IPO cannabinoid (NASDAQ: TRPX)
TEL AVIV, Israel, March 22, 2017 /PRNewswire/ --
Therapix Biosciences Ltd. (NASDAQ: TRPX) (TASE: THXBY), a specialty clinical-stage pharmaceutical company specializing in the development of cannabinoid-based drugs, today announced the pricing of its initial public offering in the United States of 2,000,000 American Depository Shares ("ADSs"). Each ADS, representing 40 ordinary shares of the Company, is offered at a price to the public of $6.00.
(NASDAQ: TRPX) IPO cannabinoid-based drugs
TEL AVIV, Israel, March 22, 2017 /PRNewswire/ --
Therapix Biosciences Ltd. (NASDAQ: TRPX) (TASE: THXBY), a specialty clinical-stage pharmaceutical company specializing in the development of cannabinoid-based drugs, today announced the pricing of its initial public offering in the United States of 2,000,000 American Depository Shares ("ADSs"). Each ADS, representing 40 ordinary shares of the Company, is offered at a price to the public of $6.00.
TRPX 9.8M Market Cap (only)
OWCP 188M Market Cap (19 X)
clinical development efforts for its two lead product candidates, including Phase II clinical trials
GWPH 2.76B Market Cap
NEWS
GD Holdings, Ltd (OTC PINK: SGDH) has signed a lease for a physical office space in Pueblo, Colorado.
The plan of implementation that CannaGrow Holdings, Inc (CGRW) followed will be the blueprint for SGD Holdings as I assist in their transition into the Cannabis Industry in the State of Colorado.
Current Share structure Mar 17 unchanged
https://twitter.com/George323818/status/843902387446145025/photo/1
fake asks
94% Sell Vol. and only -6% !
Month of March Has Been Huge for SGD HOLDINGS LTD COM NPV (OTCMKTS:SGDH)
March 16, 2017
http://streetregister.com/2017/03/16/month-of-march-has-been-huge-for-sgd-holdings-ltd-com-npv-otcmktssgdh/
Only 65K to 0.13
Agree! Intelligent words.
SGDH NEWS up +22%
0.13 MJ play
SGD Holdings, Ltd Looks Toward Expansion Into Colorado With Addition of New Member of Board of Directors
VENTURA, CA -- (Marketwired) -- 03/07/17 -- SGD Holdings, Ltd (OTC PINK: SGDH) announced today that Delmar Janovec, CEO of CannaGrow Holdings (OTC PINK: CGRW), has joined the Board of Directors of SGD Holdings, Inc as the company looks toward opportunities in Colorado.
$SGDH next CGRW style
SGDH up +22% 0.13 MJ play
NEWS
SGD Holdings, Ltd Looks Toward Expansion Into Colorado With Addition of New Member of Board of Directors
VENTURA, CA -- (Marketwired) -- 03/07/17 -- SGD Holdings, Ltd (OTC PINK: SGDH) announced today that Delmar Janovec, CEO of CannaGrow Holdings (OTC PINK: CGRW), has joined the Board of Directors of SGD Holdings, Inc as the company looks toward opportunities in Colorado.
$SGDH next CGRW style
News CGRW
03/15/17 -- CannaGrow Holdings, Inc. , (OTC PINK: CGRW) -- A Liaison and Consultant providing turnkey solutions to licensed growers, CannaGrow Holdings, Inc. , announces Category One Botanicals, LLC , the Licensed Grower, has received the lab analysis on the first Winer Test Run in the Ranger Series 2000 Climate Controlled Greenhouse.
Last flippers
SGDH MJ play up +37% 0.11
NEWS
SGD Holdings, Ltd Looks Toward Expansion Into Colorado With Addition of New Member of Board of Directors
VENTURA, CA -- (Marketwired) -- 03/07/17 -- SGD Holdings, Ltd (OTC PINK: SGDH) announced today that Delmar Janovec, CEO of CannaGrow Holdings (OTC PINK: CGRW), has joined the Board of Directors of SGD Holdings, Inc as the company looks toward opportunities in Colorado.
$SGDH next CGRW style
SGDH up +37% 0.11 MJ play
NEWS
SGD Holdings, Ltd Looks Toward Expansion Into Colorado With Addition of New Member of Board of Directors
VENTURA, CA -- (Marketwired) -- 03/07/17 -- SGD Holdings, Ltd (OTC PINK: SGDH) announced today that Delmar Janovec, CEO of CannaGrow Holdings (OTC PINK: CGRW), has joined the Board of Directors of SGD Holdings, Inc as the company looks toward opportunities in Colorado.
$SGDH next CGRW style
90% buy vol.
Only 45K to 0.115
News ?!
DDAmanda print ?!
Obviously, I agree with you.
new dividend, paying back $2.5 million to common shareholders record as of March 15,2017
$DRYS
http://dryships.irwebpage.com/press/dryspr020717.pdf
- Cash and cash equivalents about $243.0 million, (or $6.70 per share)
- Book value of Vessels, net about $95.3 million
- 3rd Party Loans about $16.5 million
- Sifnos Loan Facility balance about $142.9 million
- Sifnos Loan available liquidity about $57.1 million
http://dryships.irwebpage.com/press/dryspr020717.pdf
$DRYS
will initiate a new dividend, paying back $2.5 million to common shareholders on a quarterly basis, starting with shareholders on record as of March 15,2017 . The dividend will likely work out to around $0.07 per share on a quarterly basis.
In November, shares of Dryships went from $38.46 to $584 within a week.
On a reverse split-adjusted basis, DryShips’ 52-week high is $2,227 .